Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > Next leg of the uptick from recent low
View:
Post by canadafan on Feb 19, 2024 9:42pm

Next leg of the uptick from recent low

We hit a recent low a few weeks ago. 
Since then a slow gradual ( very slow) climb.
Annoucement last week of yet another trial with Roche ( tripplng of standard of care & one complete recovery) all good stuff
I expect the next leg of Sp recovery this week. As we come closer to year end and Q2 update, they need a lot of things clarified.
I still sense they are in disaster recovery mode since Pancan backed away. 
could the Roche additional trial be a continuaton of existing terms? 
A buisness deal is needed and soon!
Comment by inthno on Feb 20, 2024 2:37pm
Hey CF, not like you to suggest the company is in disaster recovery mode, Also you are wrong on "yet another trial with Roche" as it is a continuation and expansion of the trial that they already had with Roche suppliing the CI, also as you state we are not going to get a q2 update but it will be a q4 and year end update that should be announced sometime most likely this week or next as ...more  
Comment by canadafan on Feb 20, 2024 3:29pm
Potato , potato...obviously I know the Q4 / year end update is coming. interesting . I did say... " year end" yet you zoom in on my obvious typo just to throw knives. Regarding " additional trial with Roche" ... had they not met the criteria in the earlier phase, that trial branch would be done. That being the " enrolment expansion of Goblet anal cancer cohort" based ...more  
Comment by inthno on Feb 20, 2024 6:07pm
Well CF it would appear you make a lot of typos and my only motive is to correct those who incorrectly pass information along to others such as you have done many times. A New advancement with Roche you say, well that is different than when you said a New trial with Roche. We already know it is just a continuation of the trial with expanded sites. And you still did not address your error in ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities